Home
Intellia Therapeutics

Intellia Therapeutics Market Share Analysis for August 2026

Intellia Therapeutics, Inc. is an American clinical-stage biotechnology company focused on developing novel, potentially curative therapeutics leveraging CRISPR-based technologies.

Finance > Investing

Domainintelliatx.com

Year Founded2014

Employees201 - 500

Annual Revenue$25M - $50M

Intellia Therapeutics

Intellia Therapeutics (including company regionals)

intelliatx.com

See more website traffic and engagement information

Intellia Therapeutics Revenue up to August 2026 is 25M - 50M

revenue generated by Intellia Therapeutics top domains

Intellia Therapeutics top domains revenue over 3 years

Revenue for Intellia Therapeutics top domains

intelliatx.com25M - 50M

See more with Sales Intelligence

Intellia Therapeutics Stock price in August 2026

Intellia Therapeutics stock is traded under the ticker #NTLA. Below you can review Intellia Therapeutics stock performance in the past 12 months up to August 2026

Total visits to Intellia Therapeutics's top domains

Understand Intellia Therapeutics market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

intelliatx.com29.5K

See more with Sales Intelligence

Avg. visit duration in Intellia Therapeutics's top domains

Analyze Intellia Therapeutics engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

intelliatx.com00:00:32

See more with Sales Intelligence

Avg. pageviews on Intellia Therapeutics's top domains

See how Intellia Therapeutics keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

intelliatx.com1.28

See more with Sales Intelligence

Intellia Therapeutics top competitors by domain

Top similar sites in August 2026, ranked by their affinity

legendbiotech.comCompany NameLegend BiotechEmployees1001 - 5000HQUnited States, New Jersey, SomersetAnnual revenue$500M - $1BTotal visits48.5KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Intellia Therapeutics

These are the website technologies, by industry, used by Intellia Therapeutics top domains

Payment & Currencies (8)

Cart Functionality

Widget (6)

Twemoji

Social (5)

Instagram

Conversion & Analytics (4)

Google Analytics

More Technologies

11

See all

News & Signals from Intellia Therapeutics

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsIntellia Therapeutics, Inc. had revenue of $7.66M on Sep 9th '26.* Intellia reported a quarterly loss of $0.80 per share, in line with estimates, but revenue of $7.66 million fell short of the $12.98 million consensus and declined 46.4% year over year.

NewsIntellia Therapeutics, Inc. received financing of $400M in non-dilutive senior secured term loan facility on Sep 4th '26.Intellia Therapeutics, Inc. announced that it has entered into a $400 million non-dilutive senior secured term loan facility with OrbiMed, a leading global healthcare investment firm.

NewsIntellia Therapeutics, Inc. is developing risk management program for nex-z. on Nov 7th '25.Intellia is working with experts to create a risk management program for nex-z.